Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195


Regulation of apoptosis by an intrinsically disordered region of Bcl-xL.

Follis AV, Llambi F, Kalkavan H, Yao Y, Phillips AH, Park CG, Marassi FM, Green DR, Kriwacki RW.

Nat Chem Biol. 2018 May;14(5):458-465. doi: 10.1038/s41589-018-0011-x. Epub 2018 Mar 5.


Perturbing mitosis for anti-cancer therapy: is cell death the only answer?

Haschka M, Karbon G, Fava LL, Villunger A.

EMBO Rep. 2018 Mar;19(3). pii: e45440. doi: 10.15252/embr.201745440. Epub 2018 Feb 19. Review.


JNK-signaling: A multiplexing hub in programmed cell death.

Dhanasekaran DN, Reddy EP.

Genes Cancer. 2017 Sep;8(9-10):682-694. doi: 10.18632/genesandcancer.155. Review.


BCL-2 family proteins: changing partners in the dance towards death.

Kale J, Osterlund EJ, Andrews DW.

Cell Death Differ. 2018 Jan;25(1):65-80. doi: 10.1038/cdd.2017.186. Epub 2017 Nov 17. Review.


Sardine oil loaded vanillic acid grafted chitosan microparticles, a new functional food ingredient: attenuates myocardial oxidative stress and apoptosis in cardiomyoblast cell lines (H9c2).

Vishnu KV, Ajeesh Kumar KK, Chatterjee NS, Lekshmi RGK, Sreerekha PR, Mathew S, Ravishankar CN.

Cell Stress Chaperones. 2018 Mar;23(2):213-222. doi: 10.1007/s12192-017-0834-5. Epub 2017 Aug 2.


Indole phytoalexin derivatives induce mitochondrial-mediated apoptosis in human colorectal carcinoma cells.

Tischlerova V, Kello M, Budovska M, Mojzis J.

World J Gastroenterol. 2017 Jun 28;23(24):4341-4353. doi: 10.3748/wjg.v23.i24.4341.


The Role of Unfolded Protein Response and Mitogen-Activated Protein Kinase Signaling in Neurodegenerative Diseases with Special Focus on Prion Diseases.

Shah SZA, Zhao D, Hussain T, Yang L.

Front Aging Neurosci. 2017 May 1;9:120. doi: 10.3389/fnagi.2017.00120. eCollection 2017. Review.


NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25A.

Yuan P, Li J, Zhou F, Huang Q, Zhang J, Guo X, Lyu Z, Zhang H, Xing J.

Cell Death Dis. 2017 Mar 23;8(3):e2704. doi: 10.1038/cddis.2017.131.


Non-apoptotic functions of BCL-2 family proteins.

Gross A, Katz SG.

Cell Death Differ. 2017 Aug;24(8):1348-1358. doi: 10.1038/cdd.2017.22. Epub 2017 Feb 24. Review.


An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells.

Chao MW, Huang HL, HuangFu WC, Hsu KC, Liu YM, Wu YW, Lin CF, Chen YL, Lai MJ, Lee HY, Liou JP, Teng CM, Yang CR.

Oncotarget. 2017 Apr 25;8(17):27772-27785. doi: 10.18632/oncotarget.15115.


Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo.

HuangFu WC, Chao MW, Cheng CC, Wei YC, Wu YW, Liou JP, Hsiao G, Lee YC, Yang CR.

Sci Rep. 2017 Feb 9;7:42291. doi: 10.1038/srep42291.


HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma.

Laporte AN, Barrott JJ, Yao RJ, Poulin NM, Brodin BA, Jones KB, Underhill TM, Nielsen TO.

PLoS One. 2017 Jan 5;12(1):e0169407. doi: 10.1371/journal.pone.0169407. eCollection 2017.


Detoxification of Mitochondrial Oxidants and Apoptotic Signaling Are Facilitated by Thioredoxin-2 and Peroxiredoxin-3 during Hyperoxic Injury.

Forred BJ, Daugaard DR, Titus BK, Wood RR, Floen MJ, Booze ML, Vitiello PF.

PLoS One. 2017 Jan 3;12(1):e0168777. doi: 10.1371/journal.pone.0168777. eCollection 2017.


Flow signaling and atherosclerosis.

Le NT, Sandhu UG, Quintana-Quezada RA, Hoang NM, Fujiwara K, Abe JI.

Cell Mol Life Sci. 2017 May;74(10):1835-1858. doi: 10.1007/s00018-016-2442-4. Epub 2016 Dec 30. Review.


Depletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability.

Wu J, He Z, Wang DL, Sun FL.

Cell Cycle. 2016 Nov;15(21):2980-2991. Epub 2016 Oct 7.


Microtubule destabilising agents: far more than just antimitotic anticancer drugs.

Bates D, Eastman A.

Br J Clin Pharmacol. 2017 Feb;83(2):255-268. doi: 10.1111/bcp.13126. Epub 2016 Oct 18. Review.


Methylsulfonylmethane Induces p53 Independent Apoptosis in HCT-116 Colon Cancer Cells.

Karabay AZ, Koc A, Ozkan T, Hekmatshoar Y, Sunguroglu A, Aktan F, Buyukbingol Z.

Int J Mol Sci. 2016 Jul 15;17(7). pii: E1123. doi: 10.3390/ijms17071123.


Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.

Zhang H, Shao H, Golubovskaya VM, Chen H, Cance W, Adjei AA, Dy GK.

Br J Cancer. 2016 Jul 12;115(2):203-11. doi: 10.1038/bjc.2016.190. Epub 2016 Jun 23.

Supplemental Content

Support Center